Lombard Odier Asset Management (USA)’s Charles River Laboratories CRL Stock Holding History

Lombard Odier Asset Management (USA)’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-2,443	Closed	-$371K	–	433
2025 Q2	$371K	Buy	+2,443	New	+$326K	0.03%	273
2017 Q4	–	Sell	-20,000	Closed	-$2.16M	–	224
2017 Q3	$2.16M	Buy	+20,000	New	+$2.05M	0.15%	132
2017 Q1	–	Sell	-62,414	Closed	-$4.75M	–	216
2016 Q4	$4.75M	Buy	62,414 +32,514	+109%	+$2.47M	0.6%	62
2016 Q3	$2.49M	Buy	+29,900	New	+$2.51M	0.23%	126

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Lombard Odier Asset Management (USA)'s CRL Position: Q3 2025 in Review

Lombard Odier Asset Management (USA) sold out of Charles River Laboratories (CRL) in Q3 2025, closing a stake of 2,443 shares — an estimated $371K sold.

Lombard Odier Asset Management (USA) first reported a position in CRL in Q3 2016 and held it in 4 quarters. The position peaked at $4.75M in Q4 2016. 556 funds tracked by Wall St. Rank hold CRL as of Q3 2025.

Lombard Odier Asset Management (USA) reported no remaining Charles River Laboratories position as of Q3 2025 after selling out during the quarter.
Lombard Odier Asset Management (USA) sold 2,443 Charles River Laboratories shares in Q3 2025, an estimated $371K.
Lombard Odier Asset Management (USA) first reported a position in Charles River Laboratories in Q3 2016 and held it in 4 quarters.
Lombard Odier Asset Management (USA)'s Charles River Laboratories position peaked at $4.75M in Q4 2016.
556 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2025.

Based on Lombard Odier Asset Management (USA)'s 13F filing for Q3 2025, filed 14 Nov 2025.